Concepedia

Yannis K. Valtis

YK

Statistics

Publications

17

Citations

432

H-Index

13

Active since

2016

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Massachusetts General Hospital

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Harvard University

Yannis K. Valtis is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and acute lymphoblastic leukemia treatment.

ORCID

Publications per year

2016–2025

17

Publications

17

Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors

Rebecca J. Vitale, Yannis K. Valtis, Marie E. McDonnell et al. · AACE Clinical Case Reports · 2020 · 54 citations · Full text

, , +16

Bone marrow drives central nervous system regeneration after radiation injury

Jörg Dietrich, Naema Nayyar, Yannis K. Valtis et al. · Journal of Clinical Investigation · 2017 · 51 citations · Full text

, , +17

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia

Shai Shimony, Yiwen Liu, Yannis K. Valtis et al. · Blood Advances · 2022 · 41 citations · Full text

, , +17

Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL

Gregory W. Roloff, Ibrahim Aldoss, Noam E. Kopmar et al. · Journal of Clinical Oncology · 2024 · 32 citations · Full text

, , +13

T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy

Kai Rejeski, Jaime Sanz, Teng Fei et al. · Blood · 2025 · 32 citations · Full text

, , +17

1–5 of 17